NASDAQ: KROS

KROS’s price-to-free cash flow ratio: A closer look at its relevance
Cameron Mitchell
Keros Therapeutics Inc (KROS)’s stock has witnessed a price hike of 1.84% from the previous close with its current price ...

Keros Therapeutics Inc (KROS)’s stock has witnessed a price hike of 1.84% from the previous close with its current price ...